---
$id: https://graph.org.ai/products/commodity/51241209
$type: Product
source: UNSPSC
code: "51241209"
title: "Hydroquinone"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hydroquinone

**UNSPSC Code**: 51241209
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an organic carcinogen with the molecular formula C6H6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XV74C1N1AE, chemically known as 1,4-hydroxybenzene but generally known as hydroquinone, which bears US NIH Compound Identifier 785. European Medicines Agency schedules Hydroquinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14140MIG. World Health Organization schedules hydroquinone in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, HYDROQUINONE remains the US FDA Preferred Term for this commodity. Hydroquinone bears US NLM identifiers UMLS ID C0020306 and NCI Concept Code C29823. SMILES: OC1CCC(O)CC1.

